Detalles de la búsqueda
1.
Early Incorporation to Palliative Care (EPC) in Patients With Advanced Non-Small Cell Lung Cancer: The PACO Randomized Clinical Trial.
Oncologist
; 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38558247
2.
A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition.
Int J Mol Sci
; 24(5)2023 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36901764
3.
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies.
Oncologist
; 26(12): 1035-1043, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34498780
4.
Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations.
BMC Cancer
; 20(1): 829, 2020 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32873256
5.
Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes.
Clin Transl Oncol
; 26(4): 836-850, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37490263
6.
Re-irradiation in patients with progressive or recurrent brain metastases from extracranial solid tumors: A novel prognostic index.
Cancer Med
; 12(1): 146-158, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35770957
7.
Nitroglycerin Plus Whole Intracranial Radiation Therapy for Brain Metastases in Patients With Non-Small Cell Lung Cancer: A Randomized, Open-Label, Phase 2 Clinical Trial.
Int J Radiat Oncol Biol Phys
; 115(3): 592-607, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35157994
8.
LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer.
Curr Oncol
; 30(1): 333-343, 2022 12 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36661676
9.
A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population.
Lung Cancer
; 174: 133-140, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36379126
10.
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma.
Front Oncol
; 11: 641975, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33959504
11.
The Evolution of Clinically Aggressive Triple-Negative Breast Cancer Shows a Large Mutational Diversity and Early Metastasis to Lymph Nodes.
Cancers (Basel)
; 13(20)2021 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34680239
12.
Risk of Developing Checkpoint Immune Pneumonitis and Its Effect on Overall Survival in Non-small Cell Lung Cancer Patients Previously Treated With Radiotherapy.
Front Oncol
; 10: 570233, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33117699
13.
Comprehensive Genomic Profile of Heterogeneous Long Follow-Up Triple-Negative Breast Cancer and Its Clinical Characteristics Shows DNA Repair Deficiency Has Better Prognostic.
Genes (Basel)
; 11(11)2020 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33227964
14.
Impact of KRASG12D subtype and concurrent pathogenic mutations on advanced non-small cell lung cancer outcomes / Impacto del subtipo KRASG12D y mutaciones patogénicas concurrentes en los resultados del cáncer de pulmón de células no pequeñas avanzado
Clin. transl. oncol. (Print)
; 26(4): 836-850, Abr. 2024. graf
Artículo
en Inglés
| IBECS (España) | ID: ibc-VR-47
Resultados
1 -
14
de 14
1
Próxima >
>>